Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John M Dye

Showing results (11-20 of 154) with videos related to

Pageof 16
Sort By:
Scientific Reports|January 14, 2016
Bispecific Antibody Affords Complete Post-Exposure Protection of Mice from Both Ebola (Zaire) and Sudan VirusesJulia C Frei, Elisabeth K Nyakatura, Samantha E Zak, et al.
Immunology Letters|September 12, 2017
Mechanistic and Fc requirements for inhibition of Sudan virus entry and in vivo protection by a synthetic antibodyDaniel Hofmann, Samantha E Zak, Elisabeth K Nyakatura, et al.
Clinical and Vaccine Immunology : CVI|February 26, 2010
Protection of nonhuman primates against two species of Ebola virus infection with a single complex adenovirus vectorWilliam D Pratt, Danher Wang, Donald K Nichols, et al.
Science (New York, N.Y.)|August 6, 2020
Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2Kui K Chan, Danielle Dorosky, Preeti Sharma, et al.
International Journal of Biological Macromolecules|April 29, 2021
Heparin: A simplistic repurposing to prevent SARS-CoV-2 transmission in light of its in-vitro nanomolar efficacyYash Gupta, Dawid Maciorowski, Samantha E Zak, et al.
Clinical and Vaccine Immunology : CVI|September 21, 2012
Profiling the native specific human humoral immune response to Sudan Ebola virus strain Gulu by chemiluminescence enzyme-linked immunosorbent assayAriel Sobarzo, Eddie Perelman, Allison Groseth, et al.
Journal of Virology|October 29, 2005
Protective cytotoxic T-cell responses induced by venezuelan equine encephalitis virus replicons expressing Ebola virus proteinsGene G Olinger, Michael A Bailey, John M Dye, et al.
The Journal of Infectious Diseases|May 7, 2015
Interferon α/β Receptor-Deficient Mice as a Model for Ebola Virus DiseaseJennifer M Brannan, Jeffery W Froude, Laura I Prugar, et al.
Viruses|April 13, 2016
Virus-Like Particle Vaccination Protects Nonhuman Primates from Lethal Aerosol Exposure with Marburgvirus (VLP Vaccination Protects Macaques against Aerosol Challenges)John M Dye, Kelly L Warfield, Jay B Wells, et al.
ACS Infectious Diseases|June 28, 2016
Cysteine Cathepsin Inhibitors as Anti-Ebola AgentsWouter A van der Linden, Christopher J Schulze, Andrew S Herbert, et al.
Pageof 16

Showing results (11-20 of 154) with videos related to

Sort By:
Pageof 16
Scientific Reports|January 14, 2016
Bispecific Antibody Affords Complete Post-Exposure Protection of Mice from Both Ebola (Zaire) and Sudan VirusesJulia C Frei, Elisabeth K Nyakatura, Samantha E Zak, et al.
Immunology Letters|September 12, 2017
Mechanistic and Fc requirements for inhibition of Sudan virus entry and in vivo protection by a synthetic antibodyDaniel Hofmann, Samantha E Zak, Elisabeth K Nyakatura, et al.
Clinical and Vaccine Immunology : CVI|February 26, 2010
Protection of nonhuman primates against two species of Ebola virus infection with a single complex adenovirus vectorWilliam D Pratt, Danher Wang, Donald K Nichols, et al.
Science (New York, N.Y.)|August 6, 2020
Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2Kui K Chan, Danielle Dorosky, Preeti Sharma, et al.
International Journal of Biological Macromolecules|April 29, 2021
Heparin: A simplistic repurposing to prevent SARS-CoV-2 transmission in light of its in-vitro nanomolar efficacyYash Gupta, Dawid Maciorowski, Samantha E Zak, et al.
Clinical and Vaccine Immunology : CVI|September 21, 2012
Profiling the native specific human humoral immune response to Sudan Ebola virus strain Gulu by chemiluminescence enzyme-linked immunosorbent assayAriel Sobarzo, Eddie Perelman, Allison Groseth, et al.
Journal of Virology|October 29, 2005
Protective cytotoxic T-cell responses induced by venezuelan equine encephalitis virus replicons expressing Ebola virus proteinsGene G Olinger, Michael A Bailey, John M Dye, et al.
The Journal of Infectious Diseases|May 7, 2015
Interferon α/β Receptor-Deficient Mice as a Model for Ebola Virus DiseaseJennifer M Brannan, Jeffery W Froude, Laura I Prugar, et al.
Viruses|April 13, 2016
Virus-Like Particle Vaccination Protects Nonhuman Primates from Lethal Aerosol Exposure with Marburgvirus (VLP Vaccination Protects Macaques against Aerosol Challenges)John M Dye, Kelly L Warfield, Jay B Wells, et al.
ACS Infectious Diseases|June 28, 2016
Cysteine Cathepsin Inhibitors as Anti-Ebola AgentsWouter A van der Linden, Christopher J Schulze, Andrew S Herbert, et al.
Pageof 16